MetaCap

Entera Bio Statistics

NASDAQ: ENTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.31+0.025 (+0.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Entera Bio by the numbers

Entera Bio has a market capitalization of $575.5 million based on 174.14M shares outstanding. With trailing EPS of $-0.40, Entera Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.8% above its 50-day average and 62.5% above its 200-day average.

Average daily trading volume is 438.35K shares, or about $1.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ENTX valuation vs. peer median

ENTX compared with the median of 8 peer companies
MetricENTXPeer medianDifference
Market cap$575.53M$571.79M+1%
Avg. volume438.35K637.10K-31%

Peer median across 8 companies: DBVT, FDMT, CGEM, SRZN, IAM, ETRA, VALN, DNA.

Valuation

Market cap
$575.53M
Price / sales (latest FY)
13,702.99
EPS (TTM)
$-0.40

Price and trading

Previous close
3.28
Open
3.25
Day range
3.18 – 3.32
52-week range
0.91 – 4.20
52-week change
+30.63%
Beta
—
Volume
468.44K

Dividends and events

Annual dividend
None
Next earnings date
Nov 13, 2026

Additional statistics

Market Cap
575.53M
Forward Pe
-6.01
Eps
-0.40
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
4.20
Week52 Low
0.91
Avg Volume
438.35K
Shares Outstanding
174.14M
Ma50
2.93
Ma200
2.03
Earnings Date
Nov 13, 2026
Pct From52w High
-21.31%
Pct From52w Low
263.19%

Related